An oral relaxin agonist developed by AstraZeneca, codenamed AZD5462, has been shown to improve cardiac function in patients ...

Takeda and Protagonist Therapeutics' hepcidin mimetic rusfertide has been approved by the FDA to treat polycythaemia vera (PV ...

The new acquisition is Lilly's ninth since the start of the year, coming just a few weeks after it agreed to buy psychedelic ...

South Korea’s mRNA ecosystem is rapidly advancing, fueled by progress from companies like GC Biopharma and EyeGene in ...

Since 2001, International Overdose Day has been observed as a moment to remember those lost to overdose and renew society’s ...

Cytokinetics has revealed the highly anticipated data from the ACACIA-HCM study of Myqorzo, which promises to take the cardiac myosin inhibitor into new territory for the class. First teased in May, ...

Through increased government investment in AI and in silico technologies, and prominent partnerships and milestones from companies like 1st Biotherapeutics, Galux, Hanmi Pharm, and LG Research AI, ...

A new, universal definition for a heart attack or myocardial infarction (MI) recognises that there are many different ...

Since taking effect in August 2024, the EU AI Act (Regulation (EU) 2024/1689) has categorised AI tools by risk level. For ...

The FDA issued approvals for Pfizer and Moderna's 2026 COVID-19 vaccines on Thursday, but is recommending them for the same ...

Sword Health, a digital therapeutics company that started in the physical therapy space, has acquired digital mental health ...

Medical technology company Boston Scientific became the target of a cyberattack this week, which disrupted some of its IT ...